This is simple. Lemoncat is ScottSmith who is Squa
Post# of 72440
Remember that these entities helped ride IPIX to almost $5 per share before the orchestrated take down. They will soon try and inflate value and take down again. This is how it works in non revenue based biotech. They did this with AMRN as 4kids had posted. The stock was brought to $20 before FDA approval, taken down to $1 and now its back to $20 with the successful study. That was done on the nasdaq so here in the OTC it’s even easier.
Lemoncat is trying to ease your return goals for you to part with shares during the run up so retail is not in control. Best to not read, listen or regard a single statement from this five headed snake.